Principal Financial Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2M | Sell |
330,134
-16,961
| -5% | -$937K | 0.01% | 886 |
|
|
2025
Q1 | $16.8M | Buy |
347,095
+9,286
| +3% | +$449K | 0.01% | 949 |
|
|
2024
Q4 | $13M | Buy |
337,809
+16,977
| +5% | +$655K | 0.01% | 1134 |
|
|
2024
Q3 | $14.4M | Buy |
320,832
+310,804
| +3,099% | +$14M | 0.01% | 1050 |
|
|
2024
Q2 | $347K | Sell |
10,028
-4,341
| -30% | -$150K | ﹤0.01% | 2033 |
|
|
2024
Q1 | $416K | Sell |
14,369
-60
| -0.4% | -$1.74K | ﹤0.01% | 2029 |
|
|
2023
Q4 | $331K | Sell |
14,429
-542
| -4% | -$12.4K | ﹤0.01% | 2036 |
|
|
2023
Q3 | $250K | Buy |
14,971
+1,068
| +8% | +$17.8K | ﹤0.01% | 2107 |
|
|
2023
Q2 | $384K | Buy |
13,903
+380
| +3% | +$10.5K | ﹤0.01% | 2012 |
|
|
2023
Q1 | $311K | Buy |
13,523
+1,785
| +15% | +$41.1K | ﹤0.01% | 2078 |
|
|
2022
Q4 | $128K | Buy |
11,738
+1,389
| +13% | +$15.2K | ﹤0.01% | 2263 |
|
|
2022
Q3 | $87K | Buy |
+10,349
| New | +$87K | ﹤0.01% | 2355 |
|
|
2022
Q1 | – | Sell |
-7,607
| Closed | -$260K | – | 2591 |
|
|
2021
Q4 | $260K | Buy |
+7,607
| New | +$260K | ﹤0.01% | 2288 |
|
|
2021
Q3 | – | Sell |
-16,540
| Closed | -$743K | – | 2613 |
|
|
2021
Q2 | $743K | Buy |
16,540
+8,364
| +102% | +$376K | ﹤0.01% | 2116 |
|
|
2021
Q1 | $212K | Buy |
+8,176
| New | +$212K | ﹤0.01% | 2369 |
|